TG Therapeutics TGTX Product — Accounts Receivable Net
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by TG Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AccountsReceivableNet.
The official record: TG Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about TG Therapeutics's product — accounts receivable net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is TG Therapeutics's product — accounts receivable net?
- TG Therapeutics (TGTX) reported product — accounts receivable net of $27.2M in Q1 2026.
- What does product — accounts receivable net mean?
- This represents the balance of payments owed to the company by customers for product shipments, net of any allowances for doubtful accounts. It reflects the efficiency of the company's credit and collection processes within its commercial segment. Monitoring this helps assess the liquidity of the company's product-related assets.